ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Colinz Laboratories Ltd submitted its Integrated Filing (Financial) for the quarter and year ended March 31, 2026. The submission includes financial results and statements regarding deviations and related party transactions as per SEBI requirements.
Colinz Laboratories Ltd submitted a declaration to BSE confirming that Regulation 32 regarding Statements of Deviation or Variation is not applicable for Q4 FY2026. The company stated it did not undertake any public, rights, preferential issues, or QIPs during the quarter, indicating no deviation in fund utilisation.
Colinz Laboratories Ltd has filed a declaration stating that Related Party Transaction disclosures under Regulation 23(9) are not applicable for the quarter ended March 31, 2026. The company is claiming exemption under Regulation 15(2)(a) of SEBI (LODR) Regulations, 2015. This is a routine regulatory compliance update.